Customer Login
Cortellis
COMPETITIVE INTELLIGENCE
TO DRIVE YOUR BUSINESS
Delivering growth – from your own innovations or strategic partnerships – is among the most urgent challenges for pharmaceutical firms. That's why Thomson Reuters Cortellis for Competitive Intelligence was developed.

Cortellis combines the same premier information used by the world’s leading pharmaceutical companies from products such as Thomson Reuters Pharma™ and Thomson Reuters Partnering (formerly IDDB). Featuring daily updates and timely drug pipeline information expertly uncovered and integrated from over 400 global meetings each year, you’ll always be on top of the latest developments.

Cortellis Scuba Diver
COMPETITIVE INTELLIGENCE
SEARCHING MADE EASY
Assess the competitive landscape and make smart, fast decisions that expand your business and develop your portfolio.
  • An easy and intuitive web-based interface – find the exact data you want, whenever you want
  • Speed decision making – with easy-to-use analytics and visualizations to quickly interrogate data
  • Share and present your findings – with agile export and reporting tools

UNPARALLELED COMPETITIVE
INTELLIGENCE WHEN YOU WANT IT, HOW YOU WANT IT
All Cortellis content is subject to an exhaustive editorial review process conducted by scientists, Pharma professionals, regulatory experts, and generics specialists. It is also updated regularly, so you get the most accurate and up-to-date information on the pharmaceutical data that matters to you.

With web-based delivery and incredibly fast search performance, you can find information anytime, anywhere, and get comprehensive drug information and competitive intelligence in just a few clicks. Offering an entirely new search interface, advanced analytic tools, and flexible packaging options, you can select the way that Cortellis works best for you.
Loading the player ...


Competitive Intelligence factsheet
Download our factsheet

Gaining a Full Picture of the Competitive Landscape for Evidence-based Decisions
Download our case study

Register for a two week trial
© Thomson Reuters – All rights resevered.

Follow @cortellis